THE SENATE

S.B. NO.

2461

THIRTY-SECOND LEGISLATURE, 2024

S.D. 2

STATE OF HAWAII

H.D. 1

 

C.D. 1

 

 

 

A BILL FOR AN ACT

 

 

RELATING TO MEDICAL CANNABIS.

 

 

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

 


     SECTION 1.  The legislature finds that amendments to the State's medical cannabis dispensary system law are necessary to facilitate the administration of the medical cannabis dispensary program and resolve matters that have arisen since the passage of Act 309, Session Laws of Hawaii 2022, and Act 108, Session Laws of Hawaii 2023.

     The purpose of this Act is to allow medical cannabis dispensaries to purchase cannabis and manufactured cannabis products from other dispensaries without any showing that such purchase is:

     (1)  Necessary for a qualifying patient's continuous access for medical use; or

     (2)  For medical, scientific, or other legitimate purposes.

     SECTION 2.  Section 329D-6, Hawaii Revised Statutes, is amended by amending subsection (r) to read as follows:

     "(r)  A dispensary may purchase cannabis and manufactured cannabis products from another dispensary.  The department [may] shall authorize a dispensary to purchase cannabis and manufactured cannabis products from another dispensary in a manner prescribed by the department by rules adopted pursuant to section 329D-27; provided that:

    [(1)  The purchasing dispensary establishes to the  department's satisfaction that:

          (A)  The purchase is necessary to ensure that qualifying patients have continuous access to cannabis for medical use; or

          (B)  The cannabis and manufactured cannabis products are for medical, scientific, or other legitimate purposes approved by the State;

     (2)] (1)  The selling dispensary may transport [no] not more than eight hundred ounces, or other amounts with prior approval by the department, of cannabis or manufactured cannabis products to the purchasing dispensary within a thirty-day period;

    [(3)] (2)  The cannabis and manufactured cannabis products are transported between the dispensaries for medical[,] sales, scientific[,] use, or other legitimate purposes approved by the State; and

    [(4)] (3)  Nothing in this subsection shall relieve any dispensary of its responsibilities and obligations under this chapter and chapter 329."

     SECTION 3.  Statutory material to be repealed is bracketed and stricken.  New statutory material is underscored.

     SECTION 4.  This Act shall take effect upon its approval.


 


 

Report Title:

DOH; Medical Cannabis; Dispensaries

 

Description:

Authorizes medical cannabis dispensaries to purchase cannabis and manufactured cannabis products from other dispensaries without showing that such purchase is necessary for a qualifying patient's continuous access for medical use, or for medical, scientific, or other legitimate purposes.  (CD1)

 

 

 

The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.